PMC:7534795 / 20151-20415
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T24819 | 7-12 | Body_part | denotes | organ | http://purl.org/sig/ont/fma/fma67498 |
T11221 | 71-79 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T40 | 7-12 | Body_part | denotes | organ | http://purl.obolibrary.org/obo/UBERON_0000062 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T182 | 191-199 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T90672 | 7-12 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organ |
T42818 | 147-149 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T126 | 45-143 | Sentence | denotes | • Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study |
T127 | 144-162 | Sentence | denotes | • >18 years of age |
T128 | 163-215 | Sentence | denotes | • Intensive care unit (ICU) COVID-19 hospitalization |
T129 | 216-264 | Sentence | denotes | • Primary endpoint of hospital-related mortality |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T87 | 71-85 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
683 | 1-58 | Disease | denotes | multi-organ damage (ChiCTR2000029765, 2020) • Tocilizumab | MESH:C564969 |
684 | 191-199 | Disease | denotes | COVID-19 | MESH:C000657245 |